Work

Interim results of phase II trial of the cyclin-dependent kinase 4/6 inhibitor PD-0332991 in refractory retinoblastoma protein positive germ cell tumors.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.4596

Authors: David J. Vaughn, Maryann Gallagher, Priti Lal, Mark Alan Rosen, Wei-Ting Hwang, Lawrence H. Einhorn, Peter J. O'Dwyer

Institutions: Abramson Cancer Center, University of Pennsylvania, Indiana University Health, Indiana University Indianapolis, Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Language: English

Topic: Testicular diseases and treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3010739291

Cites:

Cited by: 3

Related to: 10